This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Genfit. Active years: 2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2022
Title: The Innovations of Isabelle Delbaere: Pioneering Therapeutic Combinations
Introduction: Isabelle Delbaere is a visionary inventor located in Loos, France. With a strong focus on therapeutic advancements, she has made significant contributions to the field of pharmacology through her innovative research and development efforts.
Latest Patents: Isabelle is credited with one notable patent titled "Combination comprising a PPAR agonist such as elafibranor and an acetyl-CoA carboxylase (ACC) inhibitor." This invention relates to a combination product intended for use in therapy, highlighting her commitment to improving treatment options for patients.
Career Highlights: Isabelle is currently employed at Genfit, a company focused on the development of innovative therapies for metabolic and liver diseases. Her work involves extensive research in the pharmacological field, leading to groundbreaking developments that can substantially impact patient care.
Collaborations: Throughout her career, Isabelle has collaborated with esteemed colleagues, including Robert Walczak and Carole Belanger. Together, they have contributed to key projects that push the boundaries of current therapeutic models and enhance the understanding of complex diseases.
Conclusion: Isabelle Delbaere’s contributions to the field of pharmacology through her innovative patent and collaborative efforts mark her as an important figure in healthcare innovation. Her dedication to improving therapeutic options underscores the importance of continuous research and development in the quest for better health solutions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile